B was established to address healthcare disparities by providing discounted medications to low-income and underserved ...

Rep. Preston Stinson (R-Edmond) and Sen. Brent Howard (R-Altus) released a joint statement following Governor Kevin Stitt’s ...

Almost half of U.S. states, 48%, are on the verge of an unpaid “family caregiving emergency.” That’s one of the key takeaways from a recent study ...

Majority Floor Leader Marilyn John (R-Richland County) introduced a bill to improve access to affordable prescription drugs ...

Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, ...

Ohio Rep. Marilyn John introduces House Bill 276 to improve the 340B program, aiding affordable medication access.

Senate Health, Education, Labor, and Pensions Committee Chairman Bill Cassidy (R-Louisiana) recently released the results of an investigation into the 340B Drug Pricing Program. Here are four key ...

David Balto is a former policy director at the Federal Trade Commission and practiced antitrust law for more than 20 years.

Tax-exempt hospitals not only avoid nearly all taxes, they also reap billions of dollars from federal prescription drug ...

Small businesses are the backbone of Oklahoma’s economy, upholding the state motto of “Labor Omni Vincit,” by employing more than 51% of our employees.

A federal judge has upheld HHS authority to oversee and regulate proposals to the 340B Drug Pricing Program, rejecting efforts of several major pharmaceutical companies to impose rebate-based discount ...

Health care costs continue to rise, forcing LGBTQ+ business owners and patients across New York to pay more for coverage and ...